You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Brett Wall is Executive Vice President and President of Medtronic’s Restorative Therapies Group (RTG) — one of four Medtronic business groups — with over $8B in annual revenue and approximately 14,000 employees worldwide. He also serves as a member of the company’s Executive Committee.
Brett has global responsibility for RTG’s four divisions, which include Brain Therapies, Pain Therapies, Specialty Therapies and Spine. He provides overall strategic direction and operational management, as well as leads the integration of the group’s activities within the overall strategy of Medtronic. Previously, he was Senior Vice President of the Brain Therapies division in RTG.
Brett also serves as the Executive Sponsor of the Medtronic African Descent Network — an internal national resource group that focuses on recruitment, engagement, retention and development for employees of African descent.
Prior to the Medtronic acquisition of Covidien, Brett served as Covidien President, Neurovascular and International, where he managed all commercial activities and functions of the business resulting in a doubling of revenue during his tenure.
He also served as Senior Vice President and President, Neurovascular; and Senior Vice President and President, International, at ev3, Inc. Prior to the ev3 merger with Micro Therapeutics, Brett held the positions of Micro Therapeutic Vice President, Marketing, for the Neurovascular and Peripheral Vascular divisions.
Brett’s career journey also included work at Boston Scientific as the Director of Marketing, Cardiovascular, Asia Pacific; and Marketing Manager, Japan, where he was responsible for the Interventional Cardiology product lines within the Asia-Pacific region. In addition, he held positions of increasing responsibility at C.R. Bard, where he was responsible for marketing the company’s suite of urological products.
Brett currently serves on the board executive committee for OCTANe, a group that promotes technical growth and expertise in the greater Orange County, California area. He also is a member of the CEO Roundtable at the University of California, Irvine. Previously, Brett served as Chairman of the Heart and Stroke Ball for the American Heart Association, Orange County Chapter.
Brett earned his bachelor’s degree in Comprehensive Business Administration with an emphasis in Marketing from the University of Nebraska at Kearney. He is a resident of Southern California.